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Abstract: Rift Valley fever phlebovirus (RVFV) infects humans and a wide range of ungulates and
historically has caused devastating epidemics in Africa and the Arabian Peninsula. Lesions of
naturally infected cases of Rift Valley fever (RVF) have only been described in detail in sheep with
a few reports concerning cattle and humans. The most frequently observed lesion in both rumi-
nants and humans is randomly distributed necrosis, particularly in the liver. Lesions supportive
of vascular endothelial injury are also present and include mild hydropericardium, hydrothorax
and ascites; marked pulmonary congestion and oedema; lymph node congestion and oedema; and
haemorrhages in many tissues. Although a complete understanding of RVF pathogenesis is still
lacking, antigen-presenting cells in the skin are likely the early targets of the virus. Following sup-
pression of type I IFN production and necrosis of dermal cells, RVFV spreads systemically, resulting
in infection and necrosis of other cells in a variety of organs. Failure of both the innate and adaptive
immune responses to control infection is exacerbated by apoptosis of lymphocytes. An excessive pro-
inflammatory cytokine and chemokine response leads to microcirculatory dysfunction. Additionally,
impairment of the coagulation system results in widespread haemorrhages. Fatal outcomes result
from multiorgan failure, oedema in many organs (including the lungs and brain), hypotension, and
circulatory shock. Here, we summarize current understanding of RVF cellular tropism as informed
by lesions caused by natural infections. We specifically examine how extant knowledge informs
current understanding regarding pathogenesis of the haemorrhagic fever form of RVF, identifying
opportunities for future research.
Keywords: Rift Valley fever phlebovirus; Bunyavirales; emerging diseases; pathogenesis; pathology;
tropism; zoonotic disease; arbovirus
1. Introduction
Rift Valley fever phlebovirus (RVFV) is a significant veterinary and public health threat
that has caused widespread outbreaks of disease in livestock and humans in most countries
in Africa and since 2000 in the Arabian Peninsula, specifically Yemen and Saudi Arabia [1].
It is caused by a mosquito-borne RNA virus of the order Bunyavirales, family Phenuiviridae.
genus Phlebovirus [2]. During years of abnormally high rainfall, vast swarms of mosquitoes,
mainly of the genera Aedes and Culex, emerge from standing water, and with sufficient num-
bers of susceptible unvaccinated livestock in the same area as RVFV-infected mosquitoes,
epidemics commence [3]. Besides transmission by mosquito bite, exposure to blood and
tissues of infected animals can transmit RVFV [4–6].
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Recurrent epidemics of Rift Valley fever (RVF) have been reported in most countries in
eastern and southern Africa since 1931 [7]. Livestock trade contributes to the spread of the
disease into disease-free areas thereby expanding the geographical distribution of RVF [8].
Between 1977 and 2007 the disease spread beyond East Africa into Egypt, Mauritania,
Somalia, and Sudan [9–15]. The disease has also spread to Madagascar, Saudi Arabia,
Yemen, the Comoros, and Mayotte [16–19].
Additionally, interepidemic circulation of RVFV is suspected to occur. Data from sero-
prevalence studies, published for several African countries, suggest that the virus might be
maintained at low levels in the environment, with sporadic clinical cases overlooked or
misdiagnosed [20]. A review of surveys conducted before 2000, demonstrates significant
high-prevalence clusters in areas that have experienced epidemics during the late 20th
century and significant low-prevalence clusters in contiguous areas of Western and Central
Africa [20]. More recently in South Africa, high seroprevalence was found in cattle (34%)
and goats (31.7%) in northern KwaZulu-Natal Province, just south of the Mozambique bor-
der, and seroconversions to RVFV were detected throughout the year [21]. Seroprevalence
in cattle, sheep, and goats in the Free State Province of South Africa is estimated as 42.9%,
28.0%, and 9.3%, respectively, and the presence of anti-RVFV IgG among domestic rumi-
nants, born after the most recent outbreak, indicates the possibility that virus circulation
has occurred during the inter-epidemic period [22]. In northern Kenya, antibodies to RVFV
were detected in samples from children born after the outbreak in 1997–1998 indicating
that low levels of transmission to humans continued in the interepidemic period [23].
Another notable example is Uganda, which before 2016 had no reports of RVF out-
breaks despite its proximity to Kenya and Tanzania where large epidemics in humans
and animals had occurred [24]. A study involving 2700 goats in southern Uganda in
2013 reported a seroprevalence of anti-RVFV IgG of 9.8% and the presence of RVF virus
neutralizing antibodies (up to 1:80), suggesting that RVF was endemic at least in goats [25].
Subsequently, between 2016 and 2018, ten outbreaks of RVF were reported in Uganda,
where cattle, goats, and sheep sampled in 2016 had a seroprevalence of 27%, 7%, and 4%
respectively [24]. Another study conducted from 2007 to 2008 on the shores of Lake Malawi
in south-western Tanzania demonstrated a seroprevalence of 29.3% in 17,000 human sub-
jects tested, with much lower rates in areas distant from the lake [26]. A recent study of
2014 and 2015 samples from the Democratic Republic of Congo reveals a country-wide
distribution of RVF with seroprevalence in cattle ranging from 16.16% in the mountainous
zones to 7.34% in the forest zones [27]. Although Rift Valley fever disease or outbreaks
have not been observed in south-western Tanzania or the Democratic Republic of Congo,
these findings suggest that the virus is circulating, and that the occasional occurrence of
disease is missed [27]. Therefore, sporadic clinical cases, not linked with high rainfall,
in both animals and humans may be overlooked or misdiagnosed in many countries in
Africa as well as endemic areas of eastern and southern Africa.
Rift Valley fever (RVF) mainly affects sheep but cattle, goats, camelids, and other wild
ruminants, particularly African buffaloes, are also susceptible [28]. The onset of disease in
cattle and sheep is marked by the onset of pyrexia, and may be accompanied by anorexia,
weakness, listlessness, a nasal discharge, diarrhoea and occasionally haematochezia and
haematuria [29]. Peracute disease occurs in lambs and calves less than two-weeks-old,
with estimated mortality as high as 90% to 100% in lambs and 10% to 70% in calves [30].
Mature livestock are significantly less susceptible to fatal disease with mortalities of ap-
proximately 10% to 30% in sheep and 5% to 10% in cattle [30]. In camels, RVF can cause
abortions and neonatal deaths, whereas infected wild ruminants are usually clinically
asymptomatic [30,31].
Epidemics are also characterised by near-simultaneous abortions of pregnant do-
mestic ruminants, African buffaloes, and camels [29,32,33]. Whereas reports regarding
abortions in cattle, camels, and African buffaloes infected with RVFV are scant, multi-
ple studies have demonstrated a wide variety of outcomes for pregnant ewes and their
foetuses [32,34–37]. Large numbers of pregnant ewes abort (90–100%) [30]. Ewes in the
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later stages of pregnancy may be more susceptible to lethal disease and die before aborting,
whereas ewes in the earlier stages of pregnancy may abort or resorb the foetus and survive
the infection [32,34,38,39]. Occasionally, RVFV infected ewes show no clinical signs, do not
seroconvert, do not have a detectable viraemia and lack lesions typical of RVF [34]. Simi-
larly, in approximately 20% of ovine foetuses, the rapid progression of placental necrosis
causes foetal mortality before foetal organs become infected [37,40]. Therefore, it may not
be possible to rule out RVF in individual cases even if sampling is adequate.
Most human infections with RVFV present as an uncomplicated acute febrile illness.
However, in a minority of patients, severe hepatic disease with haemorrhagic manifesta-
tions, renal impairment, encephalitis, and ocular lesions can complicate illness [41]. Addi-
tionally, RVFV can replicate in the syncytiotrophoblast layer of the human placenta and its
vertical transmission correlates with an increased risk of miscarriage in humans [41–44].
Available literature about the viral haemorrhagic form of RVF is scant. Here, through
an examination of RVFV’s cellular tropism, and its implications specifically for this mani-
festation of RVF, we identify knowledge gaps and several warranted avenues for future
research. First, we present an overview of the virus. We follow this with a discussion
of RVFV’s cellular tropism as demonstrated in examinations of macro- and microscopic
lesions in animals and humans who succumbed to natural RVFV infections. Accompany-
ing this section are a series of images derived from cases we published prior [37,45,46].
Information regarding these—including immunohistochemistry methods—are already
available [47]. We use standard special stains to highlight additional features relevant to
this discussion. Finally, we examine RVF within the context of what is known about other
viral haemorrhagic fevers including dengue haemorrhagic fever, yellow fever, Crimean-
Congo haemorrhagic fever, Marburg, Ebola and Lassa, since there are many similarities
between the pathology and pathogenesis of these diseases and RVF.
2. Aetiological Agent
2.1. Structure and Replication
Rift Valley fever virus is an enveloped, single-stranded RNA virus with only one
serotype and multiple lineages [48–50]. The viral genome consists of three segments, large,
medium, and small (L, M, and S) [51]. Similar to other arboviruses such as bluetongue
and epizootic haemorrhagic disease virus, RVFV’s genome has low substitution rates, with
genomic diversity largely driven by reassortment [49]. The L RNA segment codes for the
viral RNA-dependent RNA polymerase while the M segment codes for the two envelope
glycoproteins, carboxy-terminus glycoprotein (GC) and amino terminus glycoprotein
(GN), as well as two non-structural proteins, NSm1 and NSm2 [52]. The S segment codes
for the viral nucleocapsid protein (N) and the nucleus-associated non-structural (NSs)
protein [51,53].
Following replication in the cytoplasm, the three viral RNA segments form ribonu-
cleoprotein complexes with the viral N protein and RNA polymerase [51,54]. The N
protein encapsidates the viral genome forming an N-RNA multimer and is also required
for its replication and transcription by the RNA polymerase [55]. Late in the infection, GC
combines with GN, forming a polyprotein that localizes to the Golgi complex where the
ribonucleoprotein complexes are also recruited by the glycoproteins [51,54]. The Golgi
complex undergoes morphological changes with vacuolization and dispersion of small
and large virus component laden vesicles in the cytoplasm, which fuse with the plasma
membrane allowing for the release of the virus into the extracellular environment [56].
The released spherical, enveloped virions measure 90–110 nm in diameter and are fur-
ther protected by a proposed T = 12 icosahedral glycoprotein layer [57–59]. The cycle
repeats after virus entry into a variety of cells, a process which is mediated by the glycopro-
teins binding to cellular receptors, followed by uptake facilitated by ribonuclease kappa
(RNASEK) [1,60].
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2.2. Cellular Receptors
In vitro experiments with human monocyte-derived dendritic cells demonstrate bind-
ing and internalization of RVFV by Dendritic Cell-Specific Intercellular adhesion molecule-
3-Grabbing Non-integrin (DC-SIGN) [61]. RVFV glycoproteins also interact with DC-SIGN,
a multifunctional C-type lectin receptor on antigen-presenting cells that interacts with
Intercellular Adhesion Molecule-3 (ICAM-3) on T lymphocytes during their activation [62].
Therefore, DC-SIGN expressed on the surface of dermal dendritic cells possibly plays a criti-
cal role in the initial transmission of RVFV following an insect bite or mucosa exposure [61].
However, this remains to be confirmed in vivo.
Also, RVFV infects other cell types, most of which do not express DC-SIGN (e.g.,
hepatocytes, adrenocortical cells, renal tubular epithelial cells). Heparan sulfate (HS) has
also been shown to facilitate RVFV entry into cells [63]. However, in the absence of HS,
Chinese hamster ovary cells are still permissible to RVFV, albeit at lower levels [63]. Hence,
another yet to be identified cellular receptor must be involved [51,61]. Liver/Lymph-
Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (L-SIGN), a homologous
molecule to DC-SIGN with similar functional interactions with ICAM-3, might play a role
in the liver tropism of RVFV [64–66]. However, L-SIGN is expressed on liver sinusoidal
endothelial cells, not hepatocytes, and acts as an attachment/capture receptor rather than
an endocytic receptor. Therefore, the details of RVFV entry into hepatocytes remain to
be clarified.
Recent studies demonstrated that the cellular tropism of RVFV coincides with the
distribution of class AI scavenger receptors (SCARA1) in tissues [45,67]. Immunola-
belling for RVFV was detected in vascular smooth muscle cells, endothelial cells and
tissue macrophages in a variety of tissues (liver, spleen, lungs, kidneys, lymph nodes,
intestinal tract, skin, and testis) all of which are known to express SCARA1 [45,68]. Uptake
of adenovirus 5, herpes simplex virus type 1 and vaccinia virus can be mediated via class A
scavenger receptors [69–71]. These findings suggest that following the initial transmission
of RVFV by dendritic cells in the skin, SCARA1 might play a secondary role in further
rounds of RVFV infection in other cells and tissues.
2.3. Role of the Non-Structural Proteins
The virus’ NSs protein has many biological functions in infected cells, which include
modulating the interferon response, facilitating efficient viral translation, and acting as
a general inhibitor of transcription [72]. The host’s antiviral interferon (IFN) system is
counteracted by the NSs protein, which prevents nuclear activation of the IFN-β gene and
the cytoplasmic transcription of interferon mRNAs [73,74]. As a result, unrestricted viral
replication is promoted. Additionally, nuclear NSs filaments bind to Sin3A Associated
Protein 30 (SAP30) and to Yin Yang 1 (the activator/repressor of interferon transcription),
forming a multiprotein repression complex on the IFN-β promoter, thereby blocking
interferon expression [75].
The NSs protein also allows for efficient viral translation and replication in infected
cells by downregulating the activation of protein kinase R (PKR) [73]. Protein kinase
R is activated by dsRNA, introduced to cells during viral replication, and once active,
PKR phosphorylates eukaryotic initiation factor 2 alpha (eIF2α), thereby suppressing viral
translation. In RVFV-infected cells, the NSs protein decreases PKR abundance and prevents
eIF2α phosphorylation, which augments viral replication [76].
The NSs protein also inhibits general transcription activity in cells by directly interact-
ing with components of the basal transcription factor II human (TFIIH) [74,77]. The p44
subunit of the TFIIH complex is sequestered by the NSs filamentous structure, thereby
blocking assembly of TFIIH and drastically reducing transcriptional activity in RVFV-
infected cells [74]. In addition, NSs protein interacts with the TFIIH subunit p62 and
promotes its post-translational degradation [77]. The presence of NSs filaments in the
nucleus of infected cells also induces DNA damage responses and causes cell-cycle arrest
which causes the activation of p53 and apoptosis [78].
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The NSs also interacts with the DNA damage response system (DDR) [78]. Specifically,
it induces up-regulation of the ataxia-telangiectasia mutated kinase (ATM) arm of the
DDR, which responds to double-stranded DNA breaks, by causing cell-cycle arrest [78].
In contrast, it down-regulates the Rad3-related kinase (ATR) pathway of the DDR, which
senses single-stranded DNA breaks and likely has an antiviral role [78]. Through this
double interaction with the DDR, NSs promotes viral replication.
Induction of apoptosis in virus-infected cells, and subsequent phagocytosis of these
cells, is one of the host defence mechanisms that eliminates infected cells thereby limiting
viral replication and spread [79]. It has been demonstrated that RVFV triggers apopto-
sis mainly through activation of caspase-8 [80]. The NSm protein of RVFV suppresses
apoptosis in target cells [80]. It suppresses the expression of caspase-8 in infected cells
thereby delaying apoptosis and ensuring the efficient release of progeny RVFV within
the first 24 h after infection [80]. As a result, most of the progeny virus is released before
virus-induced apoptosis occurs. Without the NSm protein, RVFV replicates poorly in
murine macrophages and has attenuated virulence in mice compared to the parental virus,
indicating NSm has a role in viral replication in mammals [81].
Virus-infected cells that undergo transcriptional or translational suppression due
to non-structural protein activity may also be exposed to tumour necrosis factor-alpha
(TNF-α) and rapidly die by apoptosis [80]. Most humans and animals do not develop fatal
RVF, presumably due to variations in the host’s innate immune responses and exposure of
the infected cells to extracellular factors, such as TNF-α, that induce apoptosis before the
completion of maximum progeny virus production [80]. This process may prevent severe,
nearly diffuse necrosis of cells in some species or age groups, preventing the death of the
host and promoting the completion of the life cycle of the virus [80].
3. Macro- and Microscopic Lesions and Virus Tropism in Natural Infections
3.1. Overview
Although RVF is known to occur in humans, a wide range of domestic and wild rumi-
nants, and camelids, lesions of naturally infected cases of RVF have only been described
in detail in sheep with a few reports concerning cattle and humans [32,35,37,45–47,82–88].
While lesions can be seen throughout the body, multifocal, randomly distributed necrosis
is the most commonly observed lesion in both ruminants and humans. Descriptions of
the lesions in natural infections of RVF are similar in humans and ruminants except for
encephalitis and retinitis that occurs in humans but has not been described in ruminants.
Furthermore, detailed studies of statistically relevant numbers of sheep and observations
in other ruminants reveal that lesions in neonatal ruminants (<1-month-old) and foetuses
differ from those observed in adult ruminants, with the most prominent differences noted
in the liver, kidneys, and lymphoid tissues [1,37,45,46,89]. While there is no clear expla-
nation for these differences, they may be due to age-related susceptibility of the primary
target cells of RVFV [1,37,45,46,89]. Immunohistochemistry based examination of the tissue
and cellular tropism of RVFV in naturally infected sheep reveals viral antigen-positive
hepatocytes, renal tubular epithelial cells, renal juxtaglomerular and extraglomerular
mesangial cells, adrenocortical epithelial cells, cardiomyocytes, Purkinje fibres, skeletal
muscle cells, epidermal keratinocytes, endothelial cells, vascular smooth muscle cells,
tissue macrophages, and neutrophils and further highlights the aforementioned age-related
differences discussed more exhaustively by organ type below [37,45,46].
In adult ruminants and neonates, lesions suggestive of vascular endothelial injury
include mild hydropericardium, hydrothorax and ascites, marked pulmonary congestion
and oedema, congestion and oedema of lymph nodes, and haemorrhages in many tis-
sues [45,46]. Conversely, in foetuses, haemorrhages are minimal but plasma leakage with
effusions in body cavities, accompanied by severe brain and lung oedema, is common [37].
Occasionally, the rapid progression of placental necrosis causes foetal mortality before other
foetal tissues can be infected [40]. Notably, foetal malformations have not been reported
in natural cases of RVF or in experimental cases using wild-type virus [32,34,37,38,40].
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Instead, ill-advised use of live attenuated vaccines in ruminants in the first or second
trimester of pregnancy should be investigated if foetal malformations are reported [90–93].
3.2. Liver
In adult cattle and sheep, innumerable petechia may be present on the parietal and
cut surfaces of the liver (Figure 1) and occasionally, there are mural haemorrhages and
intraluminal blood in the gall bladder [32,35,45,86]. Histologically, foci of necrosis are
situated irregularly throughout the lobule in adult ruminants and might involve up to
two-thirds or more of the lobule (Figure 2). A diagnostically significant finding is that
necrosis often extends into the periportal zones, affecting hepatocytes of the limiting plate
which is typically not seen with liver injury due to hepatotoxins [45]. Haemorrhage and a
mild to moderate infiltrate of neutrophils, lymphocytes, and macrophages are generally
also present in and surrounding necrotic areas [45]. This is accompanied by a mild infiltrate
of mononuclear inflammatory cells in the portal tracts, with occasional karyorrhexis of
mononuclear cells in the portal interstitium [45].
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In calves and lambs less than a month-old, pale pinpoint subcapsular petechiae and
foci of necrosis may be present in the liver and virtually all hepatocytes undergo necrosis
(Figure 1) [32,35,46]. In foetuses, the liver usually does not have any discernible macro-
scopic lesions [37]. However, microscopically there is random dropout of hepatocytes from
the reticulin framework which ranges from minimal to nearly diffuse hepatocyte necrosis.
Haemorrhage or pooling of blood in spaces depleted of hepatocytes is inconspicuous in
foetuses whereas oedema is present in the portal areas in most cases (Figure 2) [37]. Bile
stasis is not present in any age category and bile ducts are not involved [32,35,37,45,46].
Injuredhepatocytes inallagegroupsoftenhavefeaturesofapoptosis (Figure 3) [32,35,37,45,46,82].
Features of early apoptotic cells (also referred to as Councilman bodies or acidophilic
bodies) include dissociation of cells, cellular shrinkage and rounding, hypereosinophilic
cytoplasm, pyknosis (nuclear chromatin condensation) and karyorrhexis (nuclear frag-
mentation) [45]. Early apoptotic bodies fragment into multiple smaller (late) apoptotic
bodies that are eosinophilic fragments of cytoplasm of varying sizes, which may or may not
contain nuclear fragments [45]. However, a lytic cell death mechanism (i.e., necroptosis or
pyroptosis) may also be involved in the pathogenesis of cell death and this is characterized
by cell swelling, rupture of the plasma membrane, and cellular collapse [46]. The latter
is especially conspicuous in neonates where many hepatocytes are severely swollen and
rounded with complete disintegration of the nucleus (karyolysis) or only small nuclear
fragments remaining (karyorrhexis) [46].




Figure 3. Histopathology of the liver in young lambs naturally infected with RVFV (H&E stain). (A) Hepatocytes with 
features of apoptosis (arrows), characterized by disassociation of cells, hypereosinophilic cytoplasm and pyknosis or 
karyorrhexis, mag 400×. (B) Diffuse necrosis of hepatocytes, filamentous eosinophilic intranuclear inclusions (arrow), 
and late apoptotic bodies (arrowhead), magnification 600×. 
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rophages that undergo degenerative changes and likewise disintegrate. This results in 
myriads of small nuclear and cytoplasmic remnants within a collapsed reticulum frame-
work (Figure 4). It is important to emphasize, however, that the absence of necrosis, pri-
mary foci, or intranuclear inclusions in the liver of foetuses does not necessarily exclude 
a diagnosis of RVF [37]. 
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karyorrhexis, mag 400×. (B) Diffuse necrosis of hepatocytes, filamentous eosinophilic intranuclear inclusions (arrow), and
late apoptotic bodies (arrowhead), magnification 600×.
Amongst the Phenuiviridae, RVFV is unique in that the NSs protein forms ribbon-like
filaments in the nucleus even though the virus replicates in the cytoplas of host cells [53].
In haematoxylin-and-eosin-stained tissue sections these rod-shaped and eosinophilic in-
tranuclear inclusions are a gnificant diagnosis-specific dicator [35,37,45,46]. A recent
study showed that intranuclea inclusions were etectable in 62% of ovine foetal liver
specimens and 38% of neonatal lamb livers [37,46]. In co trast, the inclusions are of
limited diagnostic value in adult ruminants and calves where they are often not identifiable
and may be confused with pseudo-inclusions.
A very distinctive feature in ruminant neonates and foetuses is discrete randomly
distributed foci of liquefactive hepatic necrosis (also referred to as primary foci) against
a background of diffuse hepatocellular death (Figure 4) [35,37,46,82,83]. Primary foci
vary in size and number and consist of lysed hepatocytes and infiltrating neutrophils
and macrophages that undergo degenerative changes and likewise disintegrate. This
results in myriads of small nuclear and cytoplasmic remnants within a collapsed reticulum
framework (Figure 4). It is important to emphasize, however, that the absence of necrosis,
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[32,45,82]. Microscopically, adult sheep, cattle, and calves frequently have a severe ne-
phrosis (Figure 6) [32,35,45,94,95]. Conversely, in young lambs (< 1-month-old) and foe-
tuses, the kidney lesion rarely progresses beyond tubular epithelial cell degeneration 
[32,37,46,82]. 
Irrespective of age, the glomeruli also appear less densely cellular than normal 
[37,45,46]. Additionally, scattered pyknosis and karyorrhexis is present within the glo-
meruli of most cases (Figure 6) and nuclear debris is also often present in the interstitial 
capillaries [37,45,46,82,83]. 
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Similarly, in human patients that died from RVF, subcapsular renal haemorrhages, 
degeneration of proximal tubular epithelial cells and a slight infiltrate of cells in the glo-
meruli are described [88]. Moreover, focal renal tubular epithelial necrosis with interstitial 
inflammation and intratubular casts were reported for a single human kidney sample [87]. 
Figure 5. I unolabelling for RVFV in the liver of sheep (polyclonal ouse anti-RVFV nucleoprotein antibody, avidin-
biotin-peroxidase detection system, NovaRED chromogen and haematoxylin counterstain). (A) In this specimen from an
adult sheep, viral antigen (arrow) is present in multiple foci in the lobule. Labelling is present in the cytoplasm of injured
hepatocytes and is diffuse or fine granular, mag 400×. (B) In young lambs, viral antigen is diffusely present in the cytoplasm
of hepatocytes, but labelling is sparse in primary foci (arrows), mag 100×.
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3.3. Kidney
Macroscopically, in the kidneys a few small cortical haemorrhages may be
present [32,45,82]. Microscopically, adult sheep, cattle, and calves frequently have a se-
vere nephrosis (Figure 6) [32,35,45,94,95]. Conversely, in young lambs (<1-month-old)
and foetuses, the kidney lesion rarely progresses beyond tubular epithelial cell degenera-
tion [32,37,46,82].
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Figure 6. Kidney of RVFV-infected adult sheep (Jones’ methenamine silver stain). (A) Lesions in necrotic tubules are
characterized by tubular epithelial cell pyknosis, karyorrhexis, and karyolysis accompanied by detachment of the epithelium
from the basement membrane (arrow), mag 200×. (B) Pyknosis and karyorrhexis are present in a renal glomerulus (arrow)
with a marked decrease in mesangial cellularity. Pyknosis is also present in the interstitium (arrowhead) and in many
tubular epithelial cells, mag 400×.
Irrespective of age, the glomeruli also appear less densely cellular than normal [37,45,46].
Additionally, scattered pyknosis and karyorrhexis is present within the glomeruli of
most cases (Figure 6) and nuclear debris is also often present in the interstitial capil-
laries [37,45,46,82,83].
Similarly, in human patients that died from RVF, subcapsular renal haemorrhages, de-
generation of proximal tubular epithelial cells and a slight infiltrate of cells in the glomeruli
are described [88]. Moreover, focal renal tubular epithelial necrosis with interstitial inflam-
mation and intratubular casts were reported for a single human kidney sample [87].
In adult sheep, immunolabeling for RVF viral antigen is most often present in the renal
cortex within glomerular and interstitial capillaries, tubular epithelial cells, and vascular
smooth muscle cells (Figure 7) [45]. In ovine neonates and foetuses, immunolabelling
within blood vessels and capillaries is more extensive, with viral antigen also often present
in the medullary interstitial capillaries [37,46]. Immunolabelling is also present at the
vascular pole of the glomerulus opposite the macula densa, within a small group of cells
that are likely juxtaglomerular and extraglomerular mesangial cells also referred to as Lacis
cells (Figure 7). Whereas this is rarely seen in adult sheep it is very common in younger
animals. Cells of the macula densa are not affected. Labelling is also more often present
in smooth muscle cells in the efferent or afferent arterioles or vascular endothelial cells in
neonates and foetuses than in adult animals. RVFV antigen was also detected in a fatal
human case in renal tubular epithelial cells [87].
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Figure 7. Immunolabelling for RVFV in the kidney of sheep (NovaRed IHC as detailed in Figure 5). (A) In this specimen
from a young lamb, viral antigen is prominent in Lacis cells in the glomerulus (arrow). Other cells, morphologically
consistent with endothelial cells also labelled in the glomerulus. Cells in the macula densa are not labelled, mag 400×.
(B) Adult sheep with immunolabelling of necrotic renal tubular epithelial cells (arrow) in the renal cortex, mag 600×.
3.4. Adrenal Gla d
In the adrenal glands, necrosis varies from individual cells to aggregates and is
found predominantly in the zona fasciculata, although occasionally cells in the zonae
glomerulosa and reticularis are also involved [35,37,45,46,82]. In sheep, irrespective of age,
immunolabelling may be present in areas of necrosis or in single cells or small groups
of apparently viable cells [45]. In ovine neonates and foetuses, viral antigen may also
be present in capillaries in the periadrenal adipose tissues or in blood vessels in the
capsule [37,46]. Lesions and viral antigen are absent from the adrenal medulla in all age
categories in sheep.
3.5. Lymphatic Organs
Typically, RVFV-infected spleens are not enlarged and occasionally they have sub-
capsular etechiae (Figure 8) [32,45,85]. Occasionally, the splee is also congested [82,83].
Microscopically, th re are v rying d grees of lymphocytolysis in the white and red pulp,
ge erally giving specimens a pauc cellular appearance [35,37,45,46,82,94,95]. I adult ru-
minants, necrosis is m s ap a en in the germinal centres, mantl zones, marginal zones,
a d peripheral zones of the periarteriolar lymphoid sheaths of the white pulp (Figure 8).
In young rumina ts and foetuses, splenic necrosis is also a prominent feature with lym-
p ocytolysis mainly involving lymphocytes in the red p lp and th periph ral aspects
of the p riarte iolar lymph id sheath [46,96]. This is mainly due to the developmentally
normal bse ce or p or development of follic lar ger nal centres, mantl cell layers, and
marginal zones in young ruminants and foetuses. Similar lesions have been reported in
humans fatally infected with RVFV, including karyorrhexis and karyolysis of lymphocyte
nuclei in the spleen and lymph nodes as well as atrophy of the white pulp [84,88].
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Macroscopically, lymph nodes are often enlarged and oedematous with scattered 
haemorrhages in the cortex and medulla [32,35,82,85]. Enlargement of the mesenteric 
lymph nodes is frequently emphasised in these reports. In the intestinal tract, lymphoid 
depletion in the lamina propria is most severe in the distal jejunum and ileum and in-
cludes moderate oedema, pyknosis, and karyorrhexis of mononuclear cells in the submu-
cosa, and a mild neutrophilic infiltrate [45,82]. Varying degrees of lymphocyte pyknosis 
Figure 8. Spleen of an RVFV-infected adult sheep. (A) Scattered sub-capsular petechiae are present. (B) Lymphocytolysis is
most apparent in the germinal centre (arrow) (H&E stain), mag 200×.
Anti-CD3 and anti- 20 i strate a marked difference in the
morphology of the spleen of e lt e co pared to RVFV infected sheep
(Figure 9). The number of re significantly reduced in both the red
and white pulp in RVF cases [ ]. i l t ich contain mostly B lymphocytes,
are often collapse . here is also an abnormal distribution of T lymphocytes, with relatively
more than normally expected present in the collapsed germinal centres. However, there is
a paucity of T lymphocytes overall. Notably, the antibodies cannot differentiate between
viable lymphocytes and dead or dying lymphocytes. Therefore, cellular debris in necrotic
germinal centres is often anti-CD20 positive.
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Figure 9. Spleen of an RVFV-infected adult sheep with sequential sections immunolabelled for T and B lymphocytes
respectively (p lyclonal rabbit anti-CD3 and anti-CD20 antibodies, micro-polymer detection system, DAB chr mogen
and haematoxy i counterst in). (A) Labelli g with the anti-CD3 antibody shows a marked lo s of T lymphocytes. Only
scattered T lym hocytes remain in the ed pul and there is severe epleti of the periarteriolar lymph sheath (arrow),
mag 100×. Inse : Spleen from a healthy control she p showing a normal distribution of abundant T lymp ocytes, mag
100×. (B) Labelling with the anti-CD 20 antibody shows necrotic debris in the germinal centre (arrow) with a few residual B
lymphocytes in the marginal zones (arrowhead) of the periarteriolar lymph sheath and in the red pulp, mag 100×. Inset:
Spleen from a healthy sheep with multiple lymphoid follicles that contain many B lymphocytes, mag 100×.
Macroscopically, lymph nodes are often enlarged and oedematous with scattered
haemorrhages in the cortex and medulla [32,35,82,85]. E largement f the mesenteric
ly ph nod is frequently emphasised in these reports. In the intesti al tract, lymphoid
de letion in the lamina propria is most severe in th dis al jejunum and ileum nd includes
moderate oed ma, pyknosis, and karyorrhexis of mononuc ear cells in the sub ucosa,
and a ild neutrophilic infiltrate [45,82]. Varying degrees of lymphocyte pyknosis and
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karyorrhexis are also present in the Peyer’s patches and correspond in degree of intensity
to the changes in other lymphoid tissues throughout the body [46,82].
In the thymus, petechiae or ecchymoses are macroscopically visible in neonatal lambs.
Histologically, haemorrhages are present in the interstitium. In both young lambs and
sheep foetuses, lymphocytolysis, which is present in other lymphoid organs, is absent in
the thymus [37,46].
In the spleen and lymph nodes, immunolabelling for RVFV is mainly in cellular
debris or macrophages, including tingible body macrophages (Figure 10) [45]. In adult
sheep, positive labelling for viral antigen is observed more readily in the white pulp, and
particularly in the marginal zone of the spleen or the sinusoids of the lymph nodes [45].
In young lambs and foetuses, labelling is also prominent in the subcapsular red pulp
and smooth muscle cells within the capsule of the spleen as well as small blood vessels
(Figure 10) [46]. Non-cell-associated antigen and antigen in endothelial cells and cellular
debris is also often present in small blood vessels in the lymphoid organs, including the
thymus, of young lambs and foetuses [37,46]. Labelling is conspicuously absent from
thymocytes [37,46].
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nificant single cell pyknosis and karyorrhexis are also occasionally present in the alveolar 
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Figure 10. Spleen of a RVFV-infected sheep (NovaRed IHC as detailed in Figure 5). (A) In this specimen from an adult sheep,
viral antigen is present in multiple macrophages in the marginal zone of the white pulp (arrow). Labelling is also present in a
tingible-body macrophage in the white pulp (arrowhead), mag 400×. (B) Prominent immu olabelling of no -cell-associated
antigen and cellular debris in the subcapsular red pulp (arrow). Viral antigen is also present in endothelial cells (arrowhead)
and the capsular smooth myocytes, mag 200×.
No convincing evidence of vascular fibrinoid necrosis or microvascular fibrin thrombi
is present in the spleen or in any organ in sheep or humans [45,84,88]. Ho ever, fibrin
deposits have been reported to occur in the red pulp of the sple n of n turally infected
cattle and calves and have a s been detected in experimentally infect d cattle [35,97].
Thrombi or fibrin deposit are also occ sionally present in the liv r sinusoids or central
v ins of cattle and within primary foci in calves [35].
3.6. Lung
In ruminants, marked lung oedema and congestion is a consistent macroscopic finding
irrespective of age (Figure 11) [35,37,45,46,82]. The lungs are often wet and heavy, with fluid
oozing from the cut surfaces and copious amounts of foam filling the trachea and bronchi.
Multifocal haemorrhages, or blood in the trachea and bronchi, may also be present in sheep
and cattle [45,82,86]. Microscopically, intra-alveolar and interstitial oedema with atelectasis,
emphysema, and occasional haemorrhages are present in adult ruminants and neonates.
In foetuses, oedema expands the connective tissue surrounding blood vessels, bronchi, or
bronchioles and is also present in the pulmonary septa [37]. Inflammatory cells, varying
from low to marked numbers, are present in the alveolar capillaries in all cases, and consist
of predominantly mononuclear cells accompanied by fewer neutrophils. Diagnostically
significant single cell pyknosis and karyorrhexis are also occasionally present in the alveolar
Viruses 2021, 13, 709 13 of 27
septa, pulmonary blood vessels, and peribronchial lymphoid tissues in all age groups of
sheep and cattle [35,45,46,82]. In fatal human RVF cases, there is frank haemorrhage in the
lungs, with microscopic alveolar oedema and haemorrhage [88].
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Figure 12. Heart of a RVFV-infected sheep (NovaRed IHC as detailed in Figure 5). (A) In this specimen from a young 
lamb, viral antigen is present in endothelial cells (arrow) and cardiomyocytes (arrowhead), mag 400×. (B) Immunolabel-
ling is especially prominent in the Purkinje fibres (arrow), mag 100×. Inset: Negative control using a following slide from 
the same case (avidin-biotin-peroxidase system using mouse polyclonal anti-Wesselsbron antibody, NovaRED peroxidase 
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Figure 11. Lungs of RVFV-infected lamb and adult sheep. (A) The interstitium in the lungs of this lamb is markedly
expanded due to oedema, and dark red areas of atelectasis are present (arrow). Multifocal petechiae are also present in the
serosa. (B) Microscopically, intra-alveolar (arrow) and interstitial (arrowhead) lung oedema is present in this adult sheep
(H&E stain), mag 100×.
In the lungs of sheep, viral antigen is present in pulmonary intravascular macrophages
or in the capillaries associated with cellular debris [37,45,46]. Immunolabelling is also
present in endothelial cells and vascular smooth muscle cells, but this is more prominent in
young lambs and sheep foetuses [37,46].
3.7. Heart
Epi- and endo-cardial haemorrhages are present in most cases in ruminants and hu-
mans [35,45,46,82,88]. However, histomorphological lesions attributable to RVFV infection
are not present in the cardiac parenchyma [35,37,45,46,88].
Immunolabelling for RVFV is rare in adult sheep and typically associated with en-
dothelial cells or vascular smooth muscle cells [45]. In neonates—and especially foetuses—
labelling in the heart is widespread and involves cardiomyocytes, Purkinje fibres, endothe-
lial cells or cellular debris in small blood vessels and capillaries, as well as in vascular
smooth muscle cells of small blood vessels (Figure 12) [37,46]. Diffuse labelling of the
myocardium and intense subepi- and endocardial labelling is occasionally observed in
foetuses [37].
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Figure 12. Heart of a RVFV-infected sheep (NovaRed IHC as detailed in Figure 5). (A) In this specimen from a young lamb,
viral antigen is present in endothelial cells (arrow) and cardiomyocytes (arrowh ad), mag 400×. (B) Immunolabelling is
especially prominent in the Purkinje fibres (arrow), mag 100×. Inset: Negative control using a following slide from the same
case (avidin-biotin-peroxidase system usi g ouse polyclonal anti-Wesselsbron antibody, NovaRED peroxidase substrate
with haematoxylin counterstain), mag 100×.
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3.8. Gastrointestinal Tract
Occasionally in cattle and sheep, marked congestion of the mesenteric and omental
vessels is present accompanied by petechiae and ecchymoses in the serosa along the entire
course of the gastrointestinal tract (Figure 13) [35,45,82,86]. Haemorrhages may also be
present in the mucosa and submucosa of the abomasum or the intestines [35,45,82]. Fresh
or partially digested blood is also frequently present in the lumen of the abomasum or
intestines in ruminants [35,82]. Histologically, small necrotic foci are occasionally present
in the lamina propria of the small intestine [45,82]. In humans, intestinal haemorrhage, foci
of necrosis in the mucosa and microscopic haemorrhages in the muscularis and subserosa
have been reported [88].
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Figure 13. Omentum and rumen of an RVFV-infected adult sheep. (A) Marked congestion of the omental blood vessels with
petechiae along the vessels and in the omental fat (arrow). (B) Petechiae and ecchymoses in the serosa of the rumen (arrow).
In adult sheep, immunolabelling for RVFV is most often present in necrotic foci in the
small intestine, either associated with cellular debris or on rare occasions in the cytoplasm
of macrophages [45]. Occasionally, epithelial cells and vascular endothelial cells in the
tongue label positively. In young lambs and sheep foetuses, viral antigen is prominent in
endothelial cells in small blood vessels and capillaries, as well as vascular smooth muscle
cells [37,46].
3.9. Subcutis and Skin
Subcutaneous haemorrhages are especially prominent on the abdomen, in the axillary region,
the medial aspect of the hind limbs and the lower portions of the extremities [32,35,45,46,82,83,86].
Immunolabelling for RVFV in sheep is often present in keratinocytes or in superfici l dermis
in association with ellular debris or vascular endothelial cells (Figure 14A) [37,45,46].
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epidermis (arrow) of an adult sheep, mag ×400. (B) Viral antigen in vascular endothelial cells and cellular debris in small 
blood vessels in the meninges (arrow) of a young lamb, mag 200×. 
3.10. Nervous System 
Other than oedema, no lesions have been reported in any tissues from the central 
nervous system of natural cases in cattle or sheep [32,35,45,46,82,83,86]. Histologically oe-
dema is especially prominent in foetuses [37]. In humans, focal areas of necrosis with an 
infiltrate of lymphocytes and macrophages may be present in the brain [88]. Perivascular 
cuffing indicative of encephalitis is also present in humans [88]. 
In sheep, viral antigen is mainly present in vascular endothelial cells or cellular debris 
in capillaries and small blood vessels in the meninges (Figure 14B). Occasionally, viral 
antigen is present in capillaries in the white or grey matter but not within the brain paren-
chymal cells. Non-cell-associated viral antigen is often present within the lumens of blood 
vessels in young lambs and sheep foetuses [45,46]. 
3.11. Reproductive Organs 
Haemorrhages may be present in the testis of sheep [45]. While immunolabelling for 
RVFV is present multifocally within the connective tissue surrounding the seminiferous 
tubules, efferent ductules, and duct of the epididymis, in vascular smooth muscle, endo-
thelial cells, macrophages, and fibroblasts, it is absent from the reproductive parenchyma 
[45]. Similarly, in the uterus of sheep haemorrhages are occasionally present in the peri-
metrium and myometrium yet viral antigen is confined to the blood vessels, and is always 
absent from the endometrium [45]. 
3.12. Placenta 
Placental lesions attributable to natural RVFV infection have only been described in 
sheep [37]. Macroscopic lesions include intercotyledonary oedema with congestion and 
necrosis of the cotyledons (Figure 15). Microscopically, oedema is prominent in the coty-
ledonary chorioallantois. The most significant histological lesion though is necrosis of 
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occur adjacent to chorioallantoic villi [37]. 
Immunolabelling for viral antigen is predominantly in trophoblasts and cellular debris 
in the cotyledonary chorioallantois (Figure 15) [37]. Occasionally binucleate and multinu-
cleated maternal syncytial cells are also viral antigen positive. Viral antigen is also present 
in vascular endothelial cells, intravascular cellular debris, or non-cell associated. Labelling 
is also occasionally present in foetal blood vessels in the chorioallantoic membranes or the 
cotyledonary chorioallantois. Viral antigen is always absent from the squamous mesothelial 
cells lining the allantoic cavity and chorionic and allantoic mesenchyme [37]. 
Figure 14. Skin and brain of RVFV-infected sheep (NovaRed IHC as detailed in Figure 5). (A) Immunolabelling in the
epidermis (arrow) of an adult sheep, mag ×400. (B) Viral antigen in vascular endothelial cells and cellular debris in small
blood vessels in the meninges (arrow) of a young lamb, mag 200×.
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3.10. Nervous System
Other than oedema, no lesions have been reported in any tissues from the central
nervous system of natural cases in cattle or sheep [32,35,45,46,82,83,86]. Histologically
oedema is especially prominent in foetuses [37]. In humans, focal areas of necrosis with an
infiltrate of lymphocytes and macrophages may be present in the brain [88]. Perivascular
cuffing indicative of encephalitis is also present in humans [88].
In sheep, viral antigen is mainly present in vascular endothelial cells or cellular
debris in capillaries and small blood vessels in the meninges (Figure 14B). Occasionally,
viral antigen is present in capillaries in the white or grey matter but not within the brain
parenchymal cells. Non-cell-associated viral antigen is often present within the lumens of
blood vessels in young lambs and sheep foetuses [45,46].
3.11. Reproductive Organs
Haemorrhages may be present in the testis of sheep [45]. While immunolabelling for
RVFV is present multifocally within the connective tissue surrounding the seminiferous
tubules, efferent ductules, and duct of the epididymis, in vascular smooth muscle, endothe-
lial cells, macrophages, and fibroblasts, it is absent from the reproductive parenchyma [45].
Similarly, in the uterus of sheep haemorrhages are occasionally present in the perimetrium
and myometrium yet viral antigen is confined to the blood vessels, and is always absent
from the endometrium [45].
3.12. Placenta
Placental lesions attributable to natural RVFV infection have only been described
in sheep [37]. Macroscopic lesions include intercotyledonary oedema with congestion
and necrosis of the cotyledons (Figure 15). Microscopically, oedema is prominent in the
cotyledonary chorioallantois. The most significant histological lesion though is necrosis
of trophoblasts and endothelial cells in the chorioallantois. In the cotyledonary villi,
necrosis of trophoblasts is generally diffuse with multifocal cellular debris between the villi.
Occasionally multifocal haemorrhages are present in the myometrium or the perimetrium
or occur adjacent to chorioallantoic villi [37].




Figure 15. Placenta of RVFV-infected sheep. (A) Diffuse necrosis of trophoblasts with cellular debris (arrow) between the 
villi (H&E stain), mag 100×. (B) Immunolabelling in trophoblasts and cellular debris (arrow) in the cotyledonary chori-
oallantois (NovaRed IHC as detailed in Figure 5), mag 400×. 
4. Comparison of Contemporary Knowledge of RVF Disease with the Pathogenesis of 
Other Viral Haemorrhagic Fever Viruses 
Rift Valley fever virus is one of many RNA viruses that causes viral haemorrhagic 
fever (VHF). The designation VHF is given to severe febrile illnesses that cause coagula-
tion defects that can lead to bleeding and increased vascular permeability resulting in hy-
potension, shock, and death [98,99]. Many of these viruses are zoonotic, including RVFV, 
making them of particular concern from both a veterinary and public health perspective 
[1,100]. In human medicine haemorrhagic fever viruses are classified into four taxonomic 
families namely, the Arenaviridae (e.g., Lassa fever virus), Bunyaviridae (e.g., Crimean-
Congo haemorrhagic fever virus and RVFV), Filoviridae (Ebola and Marburg viruses) and 
the Flaviviridae (dengue haemorrhagic fever virus and yellow fever virus) [101]. There ap-
pear to be many similarities between the pathology and pathogenesis of all the viral haem-
orrhagic fevers [99]. Therefore, some of what is unknown about the pathogenesis of RVF 
can be deduced from studies concerning other VHF viruses such as Ebola virus (EBOV), 
Crimean-Congo haemorrhagic fever (CCHF) virus (CCHFV), dengue haemorrhagic fever 
(DHF) virus (DHFV), Marburg haemorrhagic fever virus or Lassa fever virus. This is not 
a comprehensive review of the considerable data on all these agents but rather a compar-
ison of a few of the better-studied diseases and their correlations to RVF. 
4.1. Model of the Pathogenic Mechanism 
All VHFs are characterized by a broad spectrum of clinical manifestations ranging 
from asymptomatic cases to mild and severe symptomatic cases with malaise, fever, vas-
cular permeability, decreased plasma volume, coagulation abnormalities and varying de-
grees of haemorrhage [100]. Common amongst the VHFs are liver damage, lymphocyte 
depletion, and abundant pro-inflammatory cytokine and chemokine production leading 
to systemic inflammatory response syndrome [99,100,102,103]. This may result in in-
creased endothelial cell permeability with oedema, impairment of the coagulation system 
(as evidenced by thrombocytopenia, consumption of clotting factors, increased levels of 
fibrin degradation and bleeding), hypotension and multiorgan failure, culminating in cir-
culatory shock in the terminal stages of disease (Figure 16) [100]. 
Detailed models representing the current understanding of VHF have been proposed 
prior [98–100]. Studies in nonhuman primates and rodents experimentally infected with 
EBOV, CCHFV, and DHFV, suggest that some of the antigen-presenting cells are early 
targets of these viruses [104,105]. Antigen-presenting cells are specialists at capturing mi-
crobial antigens, breaking them into small peptides, and displaying these to the appropri-
ate T lymphocytes thereby inciting the adaptive immune response [106]. Antigen-present-
ing cells include dendritic cells of the dermis, spleen, and lymph nodes, Langerhans’ cells 
in the epidermis, macrophages, B lymphocytes, and type II and type III epithelioreticular 
Figure 15. Placenta of RVFV-infected sheep. (A) Diffuse necrosis of trophoblasts with cellular debris (arrow) between
the villi (H&E stain), mag 100×. (B) Immunolabelling in trophoblasts and cellular debris (arrow) in the cotyledonary
chorioallantois (NovaRed IHC as detailed in Figure 5), mag 400×.
Immunolabelling for viral antigen is predominantly in trophoblasts and cellular debris
in the cotyledonary c orioallantois (Figure 15) [37]. Occasionally binucleate and multinu-
cleated maternal syncytial cells are also viral antigen positive. Viral antigen is also present
in vascular endothelial cells, intravascular cellular debris, or non-cell associated. Labelling
is also occasionally present in foetal blood vessels in the chorioallantoic membranes or the
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cotyledonary chorioallantois. Viral antigen is always absent from the squamous mesothelial
cells lining the allantoic cavity and chorionic and allantoic mesenchyme [37].
4. Comparison of Contemporary Knowledge of RVF Disease with the Pathogenesis of
Other Viral Haemorrhagic Fever Viruses
Rift Valley fever virus is one of many RNA viruses that causes viral haemorrhagic
fever (VHF). The designation VHF is given to severe febrile illnesses that cause coagulation
defects that can lead to bleeding and increased vascular permeability resulting in hypoten-
sion, shock, and death [98,99]. Many of these viruses are zoonotic, including RVFV, making
them of particular concern from both a veterinary and public health perspective [1,100].
In human medicine haemorrhagic fever viruses are classified into four taxonomic fami-
lies namely, the Arenaviridae (e.g., Lassa fever virus), Bunyaviridae (e.g., Crimean-Congo
haemorrhagic fever virus and RVFV), Filoviridae (Ebola and Marburg viruses) and the
Flaviviridae (dengue haemorrhagic fever virus and yellow fever virus) [101]. There appear
to be many similarities between the pathology and pathogenesis of all the viral haemor-
rhagic fevers [99]. Therefore, some of what is unknown about the pathogenesis of RVF
can be deduced from studies concerning other VHF viruses such as Ebola virus (EBOV),
Crimean-Congo haemorrhagic fever (CCHF) virus (CCHFV), dengue haemorrhagic fever
(DHF) virus (DHFV), Marburg haemorrhagic fever virus or Lassa fever virus. This is not a
comprehensive review of the considerable data on all these agents but rather a comparison
of a few of the better-studied diseases and their correlations to RVF.
4.1. Model of the Pathogenic Mechanism
All VHFs are characterized by a broad spectrum of clinical manifestations ranging from
asymptomatic cases to mild and severe symptomatic cases with malaise, fever, vascular
permeability, decreased plasma volume, coagulation abnormalities and varying degrees of
haemorrhage [100]. Common amongst the VHFs are liver damage, lymphocyte depletion,
and abundant pro-inflammatory cytokine and chemokine production leading to systemic
inflammatory response syndrome [99,100,102,103]. This may result in increased endothelial
cell permeability with oedema, impairment of the coagulation system (as evidenced by
thrombocytopenia, consumption of clotting factors, increased levels of fibrin degradation
and bleeding), hypotension and multiorgan failure, culminating in circulatory shock in the
terminal stages of disease (Figure 16) [100].
Detailed models representing the current understanding of VHF have been proposed
prior [98–100]. Studies in nonhuman primates and rodents experimentally infected with
EBOV, CCHFV, and DHFV, suggest that some of the antigen-presenting cells are early
targets of these viruses [104,105]. Antigen-presenting cells are specialists at capturing mi-
crobial antigens, breaking them into small peptides, and displaying these to the appropriate
T lymphocytes thereby inciting the adaptive immune response [106]. Antigen-presenting
cells include dendritic cells of the dermis, spleen, and lymph nodes, Langerhans’ cells in
the epidermis, macrophages, B lymphocytes, and type II and type III epithelioreticular
cells of the thymus [106]. It is thought that early in the infection the virus is endocytosed
by antigen-presenting cells in the mucosa or the skin [100,102]. Virus gains entry via the
bite of an infected insect (e.g., RVFV, CCHFV, or DHFV), breaks in the skin (e.g., EBOV),
or through exposure to excreta of infected rodents (e.g., Lassa fever virus) [1,100,104]. Virus
replicates in the cytoplasm of macrophages or dendritic cells at the site of viral entry and
is then conveyed to the lymph nodes and parenchymal cells in the liver, kidney, adrenal
cortex, and other organs. Fragmentation of many cells via necrosis or apoptosis, with
phagocytosis of cell remnants, promotes further systemic dissemination of virus [100,102].
Presumably, tissue macrophages and vascular endothelial cells become secondarily in-
fected and systemic inflammatory response syndrome, accompanied by microcirculatory
dysfunction and shock follows [102].
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Figure 16. Model of the pathogenic mechanism underlying RVFV infection. Following a mosquito bite, the virus is endo-
cytosed by antigen-presenting cells. Suppression of type I IFN production and necrosis of infected macrophages and den-
dritic cells cause wide dissemination of viruses. This systemic spread leads to necrosis in a variety of tissues and cells 
together with suppression of both the innate and adaptive immune responses. Apoptosis of lymphocytes might occur 
through mediator effects and loss of dendritic cell support, exacerbating the failure of the immune response. An excessive 
Figure 16. Model of the pathogenic mechanism underlying RVFV infection. Following a mosquito bite, the virus is
endocytosed by antigen-presenting cells. Suppression of type I IFN production and necrosis of infected macrophages
and dendritic cells cause wide dissemination of viruses. This systemic spread leads to necrosis in a variety of tissues and
cells together with suppression of both the innate and adaptive immune responses. Apoptosis of lymphocytes might
occur through mediator effects and loss of dendritic cell support, exacerbating the failure of the immune response. An
excessive pro-inflammatory cytokine and chemokine response follow, resulting in increased microcirculatory dysfunction
through the action of inflammatory mediators. Impairment of the coagulation system results in widespread haemorrhages.
Fatal outcomes result from multiorgan failure, oedema in many organs (including the lungs and brain), hypotension and
circulatory shock. DC, dendritic cell. NO, nitric oxide. (Illustration adapted from Bray M, 2005).
4.2. The Role of the Liver and Kidney
Hepatocellular death is common in all VHFs [102]. In RVF, the pathogenic mechanisms
for hepatocyte death include apoptosis, induced by the presence of NSs as discussed
earlier [78,107]. However, RVFV also induces the formation of nucleotide-binding domain,
leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasomes that
activate caspase-1 leading to the maturation of interleukin 1β and interleukin-18 and the
induction of pyroptosis [108]. The latter, in contrast to apoptosis, is a lytic cell death
mechanism characterized by cell swelling, rupture of the plasma membrane, and cellular
collapse [109,110].
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In some cases of VHF, fulminant hepatic failure follows, however, hepatocellular
lesions are often not significant enough to cause death [102]. Acute renal dysfunction
may also play a role in the pathogenesis of VHFs with a fatal outcome. In the recent
EBOV outbreak in Sierra Leone, patients had evidence of both hepatocellular damage and
impaired kidney function and these were characterized by increased levels of liver en-
zymes, creatinine, blood urea nitrogen, and other markers [111]. Increased deviation from
normal values for blood urea nitrogen (BUN), aspartate aminotransferase, and creatinine
predicted a fatal outcome. In Marburg haemorrhagic fever, renal dysfunction presenting as
proteinuria, with pale swollen kidneys, is frequently observed in fatal cases [112].
Similar findings are reported in RVF for both humans and ruminants. In a clinical
study of severe illness due to RVFV infection in 165 human patients in Saudi Arabia, 69
were diagnosed with hepatic failure alone, 55 with both hepatic and renal failure, and
13 with renal failure alone, of which respectively 12, 39, and 3 patients died [41]. Acute
renal failure associated with RVF was also described in hospitalized human patients in
Sudan where 85 of 194 patients had signs and symptoms of renal failure without hepatic
involvement [113]. Similarly, research comparing the susceptibility of three breeds of
Nigerian sheep to experimental RVFV infection revealed increased BUN values in study
participants starting on day three post-infection and continuing until the animals died [114].
Another experimental study also reported increased BUN values and histopathological
changes indicative of renal injury in several sheep and cattle [94,97].
Renal dysfunction is also occasionally a serious complication of fulminant liver failure
secondary to the development of portal hypertension, which then leads to splanchnic
and systemic vasodilatation [115]. Vasodilatation, mediated by nitric oxide and other va-
sodilators, causes relative hypovolaemia and reduced effective central blood volume [115].
However vascular damage with plasma leakage causing non-dependant oedema and fluid
sequestration in the body cavities may also exacerbate hypovolaemia and contribute to
the development of renal failure. In DHF, the most severely affected children develop
dengue shock syndrome due to excessive depletion of intravascular volume due to plasma
leakage, accompanied by only minor bleeding manifestations, most commonly skin pe-
techiae or bruising [116]. In Lassa fever, vascular damage with capillary leakage is also
more prominent than haemorrhage, and results in pleural effusion, pericardial oedema,
and hydropericardium in severe cases [117]. Similarly, in ovine neonates and foetuses
that died from RVF, haemorrhages are minimal in most cases whereas brain and lung
edema as well as body cavity effusions are common [37,46]. Hypovolaemia may also be
further exacerbated by reduced synthesis of albumin by the liver and impaired secretion of
steroid synthesizing enzymes by virus-infected adrenal cortical cells [102]. Adrenal cortical
cells are permissive to infection by many VHF viruses including RVFV [37,45,46,94,95].
Reduced albumin leads to reduced plasma oncotic pressure and contributes to plasma
leakage, whereas reduced levels of steroid synthesizing enzymes from the adrenal glands
may contribute to hypotension and sodium loss [102]. Finally, renal impairment may also
occur because of direct virus-related injury of kidneys, which has been demonstrated in
both ovine and human RVFV infections [32,41,82,87,94,95,118].
4.3. Coagulation Disorders
VHFs also cause a diversity of coagulation disorders that present either as widespread
bleeding or as thrombosis [99]. Humans and animals with severe illness due to RVFV may
have bleeding from the gums, haematemesis, haemoptysis, epistaxis, melaena, haema-
turia, vaginal bleeding, petechial rashes and ecchymoses of the skin, or bleeding from
venipuncture sites [29,41,45,86,119,120]. Conversely, thrombosis is described in earlier
studies in ruminants, wherein mention is made of thrombosis of the central veins of the
liver in 3 of 34 lambs, and fibrin thrombi in 6 of 30 adult cattle and calves [35,82]. Coronary
thrombosis was also reported in one human patient in 1951, but cardiovascular disease
was not excluded in this patient who also had a ‘tight feeling over the chest’ and refused
hospitalization [121]. In contrast, lesions that were described in four patients that died
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from RVF during the outbreak in 1975 in South Africa did not mention microthrombi in
any of the tissues [88]. Additionally, there was no convincing evidence of vascular fibrinoid
necrosis or microvascular fibrin thrombi in any organ in recent studies of natural sheep
cases [37,45,46]. Therefore, evidence of thrombosis in RVF is contradictory.
The mechanisms of widespread bleeding in VHFs have often been attributed to direct
viral infection or damage of vascular endothelial cells and thrombocytopenia [99]. Throm-
bosis has been ascribed to the release of pro-inflammatory cytokines and chemokines
from virus-infected endothelial cells and monocytes/macrophages [99]. Disseminated
intravascular coagulation (DIC) possibly follows, because of the activation of the coag-
ulation cascade and a reduction in the production of coagulation factors due to severe
hepatic necrosis. However, DIC can be classified as either enhanced-fibrinolytic-type DIC
(fibrinolytic DIC) or suppressed-fibrinolytic-type DIC (thrombotic DIC) [122].
In thrombotic DIC (e.g., in sepsis) multiple microthrombi form in circulation due to
coagulation cascade activation [122]. However, because plasminogen activator inhibitor
is overexpressed in the vascular endothelium, fibrinolysis is suppressed and many mi-
crothrombi remain, causing multi-organ failure [122]. Laboratory findings include an
elevation in thrombin–antithrombin complex (TAT), a coagulation activation marker, and
only mildly elevated plasmin-α2 plasmin inhibitor complex (PIC), a fibrinolysis activation
marker. Fibrin/fibrinogen degradation products (FDPs) and D-dimer levels are also ele-
vated, and bleeding complications are relatively mild in thrombotic DIC. In contrast, in
fibrinolytic DIC, microthrombi are histologically difficult to demonstrate due to enhanced
fibrinolytic activation [122]. Laboratory findings include a steep increase in PIC, but only a
mild increase in the activity of plasminogen activator inhibitor, the fibrinolytic inhibitory
factor [122]. Additionally, levels of TAT, D-dimers and FDPs, which reflect the dissolution
of microthrombi, are also elevated. Bleeding symptoms in enhanced fibrinolytic DIC are
severe, and life-threatening bleeding may occur [122].
The occurrence of DIC in human RVF cases in Saudi Arabia has been reported but was
inadequately characterized to enable classification as either fibrinolytic or thrombotic [5,41].
More recently though, a study of 3 human RVF cases in Uganda demonstrated elevated
D-dimer and tissue plasminogen activator levels, which is consistent with increased fib-
rinolysis [123]. In DHF, it was demonstrated that levels of FDPs are not elevated to a
degree consistent with thrombotic DIC [116]. Instead, fibrinolytic DIC occurs in DHF
wherein degradation of fibrinogen prompts secondary activation of procoagulant homeo-
static mechanisms [124]. In sheep, experimentally infected with RVFV, thrombocytopenia
and prolonged prothrombin and clotting times are present and plasma fibrinogen levels
fluctuate during the period of RVFV infection [114]. In a wild-type RVFV rhesus macaque
infection study, 3 of 15 animals had haemorrhagic disease accompanied by thrombocy-
topenia, prolonged prothrombin and clotting times and significant decreases in FDPs and
fibrinogen levels, again consistent with fibrinolytic DIC [125]. Consequently, it seems
unlikely that microthrombi play a significant role in the pathogenesis of RVF.
4.4. Suppression of the Immune System
Dysregulation of the inflammatory response also contributes to a fatal outcome in
VHF. Wild-type RVFV infection of human monocyte-derived macrophages can lead to
a productive infection and inhibition of the innate immune response via decreased ex-
pression of IFN-α2, IFN-β, and TNF-α [126]. In human patients infected with RVFV,
interleukin-8 (IL-8) and interleukin-6 (IL-6) levels were increased and were at similar levels
in fatal cases and survivors [123,127]. Interleukin-8 is a pro-inflammatory chemokine
produced by macrophages in response to infection, while IL-6 is an important mediator of
fever [127]. Serum levels of monokine-induced-by-gamma-interferon (MIG), interferon-
gamma-induced-protein-10 (IP-10), and interleukin-10 (IL-10) were significantly increased
while the chemokine RANTES (regulated-upon-activation-normal-T-cell-express-sequence)
was significantly decreased in fatal human RVFV cases relative to survivors and con-
trols [127]. This suggests an imbalance in the immune response in fatal RVFV cases,
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because MIG, IP-10, and RANTES are pro-inflammatory chemokines whereas IL-10 is
immunosuppressive. This imbalance would contribute to the failure of adaptive immune
responses to clear the infection in fatal cases and explain why RVFV replicates to signifi-
cantly higher levels in patients with fatal outcomes, but the details of such a model remain
to be determined [127,128].
4.5. Lymphocytes
Interestingly none of the VHF viruses infects lymphocytes. However, their rapid
loss by apoptosis is a prominent feature of these diseases and lymphocytolysis is often
noted [100,103,129]. In Ebola subtype Zaire, MARV and RVFV infections, lymphoid de-
pletion affects the centres of B-cell follicles in lymph nodes [45,129]. Fatal outcomes in
humans infected with Ebola subtype Zaire are also characterized by very low levels of
circulating cytokines produced by T lymphocytes and by the massive loss of peripheral
CD4+ and CD8+ lymphocytes, causing a profound suppression of the adaptive immune re-
sponses [103]. However, the innate immune responses are also impaired by Ebola subtype
Zaire infection which is characterized by hypersecretion of numerous pro-inflammatory
cytokines, chemokines, and growth factors, and by the significant absence of a type I
interferon production [103]. The cause of lymphocytolysis in VHF’s is unknown and
further study of the pro-inflammatory cytokine milieu and its potential relationship to
the observed lymphocytolysis caused by natural RVFV infections is warranted, because
laboratory animal models such as the mouse have produced contrary findings [127].
4.6. The Central Nervous System
Encephalitis, a complication of RVF in humans, has been experimentally reproduced
in mice and rats, but has not been described in sheep or any other ruminants [41,130,131].
Neurologic disease has also been described in other VHFs such as Lassa fever, DHF, and
Marburg haemorrhagic fever [112,132,133]. Meningoencephalitis associated with RVFV
infection was described in 7 of 165 patients in Saudi Arabia and accompanied by either
retinitis (n = 5), hepatitis (n = 3), or kidney failure (n = 1) [41]. In experimental infection
studies in marmosets and African green monkeys, RVFV also causes encephalitis [134].
Previously, in fatal human RVF cases, focal necrosis with an infiltrate of mononuclear cells
and perivascular cuffing in the central nervous system (CNS) has been described [88]. This
finding together with the delayed-onset encephalitis and/or retinitis in humans suggests
an inadequate adaptive immune response [41,135]. Additionally, an increased mortality
rate is seen in human patients infected with both RVFV and human immunodeficiency
virus (HIV), and all these patients present with CNS symptoms [136]. Trafficking of
the virus across the blood-brain barrier, a layer of vascular endothelial cells reinforced
by tight junctions between the cells and supported by astrocytes and pericytes, might
be blocked by RVFV-neutralizing antibodies [131]. Experiments in wild-type mice and
monocyte recruitment deficient CCR2 knockout mice, variously depleted of CD4+ and
CD8+ T lymphocytes and infected with NSs gene deleted RVFV, demonstrated that both
CD4+ and CD8+ T cell populations and monocytes were critical for prevention of RVFV-
neurologic disease and that this immune control occurs in the periphery not the central
nervous system [135]. Furthermore, as shown by markedly decreased neutralizing antibody
responses and increased viral loads in the CD4+ lymphocyte depleted mice, activation
of CD4+ T lymphocytes is requisite to augment RVFV antibody affinity maturation and
class switching in B lymphocytes [137]. Therefore, individuals with CD4+ T lymphocyte
dysfunction might be at an increased risk of developing severe RVF, including encephalitis.
Notably, it has not been established exactly how RVFV crosses the blood-brain barrier.
Aerosol or intranasal exposure might be necessary since encephalitis occurs in laboratory
animals exposed to RVFV via this route rather than via subcutaneous injection [107,138,139].
Furthermore, although RVFV is mosquito-transmitted, consuming or handling products
from sick animals, including slaughtering sick livestock, and handling dead foetuses is
associated with severe disease or death [4–6]. Therefore, RVFV might infect peripheral
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sensory and motor neurons in the eyes or oronasal mucosa directly, causing encephalitis
and retinitis via these routes [140]. Immunocompetent Lewis rats exposed to wild-type
RVFV by aerosolization develop lethal encephalitis and have low levels of viral RNA in
their eyes [141]. Lethal disease in these rats is also accompanied by increases in mono-
cyte chemoattractant protein-1 (MCP-1), macrophage colony-stimulating factor (M-CSF),
keratinocyte chemoattractant/human growth-regulated oncogene (Gro/KC), RANTES,
and IL-1β, all evident in the serum before the onset of clinical disease, and these increases
are followed by an inflammatory derangement in the brain during clinical illness [141].
It has been hypothesised that these chemokines may be actively recruiting monocytes,
macrophages, and neutrophils into the CNS [141]. Additionally, aerosol exposure of rats to
wild-type RVFV has demonstrated that neurological symptoms commence concomitant
with increased vascular permeability and possible brain oedema, and that virus replication
occurs in the brain several days before vascular leakage is detected [142]. Therefore, in
some species at least, RVFV seemingly enters the CNS via olfactory neurons where replica-
tion of virus causes inflammation and increased vascular permeability, with concomitant
release of chemokines that attract mononuclear cells to the CNS and cause neurological
symptoms. Unfortunately, though, this still does not explain why ruminants have never
been reported to develop encephalitis, since it seems likely that they would encounter
aborted foetuses and placentas.
5. Conclusions
Outbreaks of RVF occur virtually every year in Africa in one or more countries.
However, the disease is often diagnosed in humans before cases in livestock are noted.
Ideally, animals should serve as sentinels to minimize loss of human life. To successfully
diagnose RVF in ruminants that died from the disease, ideally tissues from multiple age
groups should be examined. Abortions in livestock are often the first indication that RVFV
is in circulation. However, diagnosing RVF in foetuses is challenging when samples from
the ewe or the placenta are not available, because foetal organ samples are often negative
for virus. A diagnosis may also be challenging during an interepidemic period when a
limited number of deaths and abortions occur, and the disease is not expected to be present.
Consequently, continued virus surveillance in endemic areas, where RVFV infection is a
plausible differential diagnosis in the interepidemic periods, is warranted. Appropriate
samples should be taken, and suitable additional tests requested.
Much is still unknown about the pathogenesis of RVF, warranting further research
in ruminants and animal models of human disease. Various components in the clotting
cascade should be studied to determine whether fibrinolysis and the formation of fibrin
thrombi occur concomitantly in RVF, thereby preventing overt thrombosis and infarction
in most cases. The possibility that SCARA1 is a cellular receptor for RVFV that might
play a role in successive rounds of RVFV infection in various tissues, also warrants further
investigation. It is also important to investigate RVFV induced changes in the levels of
various lymphocyte subsets and the circulating cytokines produced by them. Specifically,
it should be determined which subset of lymphocytes is worst affected, at what time-
point post-infection this occurs, and how this affects the adaptive immune response. The
finding that RVFV infects cells in the testis raises the question of whether the virus can be
sexually transmitted. Studies in ruminant models might show if viable virus is present in
semen, and if confirmed, how long individuals potentially remain infectious. Lastly a clear
understanding of why RVFV induced encephalitis occurs in humans but not in ruminants
might provide a course of action to prevent this devastating complication of RVF.
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